发明名称 |
4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one and an mtor inhibitor |
摘要 |
602807 Disclosed is the use of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]- 1H-quinolin-2-one (dovitnib) or a tautomer thereof or a mixture thereof, or a pharmaceutically acceptable salt thereof, and at least one mTOR inhibitor in the manufacture of a medicament for the treatment and prevention of a proliferative disease or a mTOR dependent disease. |
申请公布号 |
NZ602807(A) |
申请公布日期 |
2014.02.28 |
申请号 |
NZ20110602807 |
申请日期 |
2011.04.14 |
申请人 |
NOVARTIS AG |
发明人 |
GRAUS-PORTA DIANA;SHI MICHAEL;EVANS DEAN BRENT |
分类号 |
A61K31/00;A61K31/436;A61K31/496;A61P35/00 |
主分类号 |
A61K31/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|